Pharmacokinetics and Distribution of Linezolid in Cerebrospinal Fluid in Children and Adolescents
Authors:
- 1 September 2010
- journal article
- research article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 29 (9) , 827-830
Abstract
Background: Two studies in hydrocephalic children and adolescents were performed to assess the penetration of linezolid into cerebrospinal fluid and its relation to meningeal inflammation. Methods: Each patient was administered intravenous linezolid 10 mg/kg every 12 hours for 3 days (study 1) or every 8 hours for 2 days (study 2). Pharmacokinetic indices (Cmax, Cmin, Tmax, AUC) were determined for plasma and ventricular fluid (VF) after the first and last doses. Results: In study 1, after the last dose, the mean Cmax values for plasma and VF were 10.30 μg/mL (range, 3.95–16.6 μg/mL) and 7.54 μg/mL (range, 2.26–12.6 μg/mL), respectively; mean Cmin values were 1.32 μg/mL (range, 0.08–3.66 μg/mL) and 1.26 μg/mL (range, 0.19–2.58 μg/mL), respectively. The VF:plasma ratio based on last dose AUC0–12 was 0.98 μg h/mL (range, 0.64–1.22 μg h/mL). In study 2, after the last dose, the mean plasma and VF Cmax levels were 9.83 μg/mL (range, 3.19–16.5 μg/mL) and 5.84 μg/mL (range, 1.82–9.34 μg/mL), respectively; mean plasma and VF Cmin levels were 1.12 μg/mL (range, 0.10–3.39 μg/mL) and 1.94 μg/mL (range, 0.34–4.62 μg/mL), respectively. The VF:plasma ratio based on last dose AUC0–8 was 0.95 μg h/mL (range, 0.62–1.31 μg h/mL). Inflammation of the meninges did not seem to influence penetration of linezolid to the VF. Conclusions: Both studies showed that VF concentrations were variable. Further investigation of the role of linezolid in the treatment of CNS infection is needed.Keywords
This publication has 17 references indexed in Scilit:
- Clinical pharmacology of linezolid: an oxazolidinone antimicrobial agentExpert Review of Clinical Pharmacology, 2008
- Pharmacologic options for CNS infections caused by resistant Gram-positive organismsExpert Review of Anti-infective Therapy, 2008
- Linezolid for the Treatment of Patients with Central Nervous System InfectionAnnals of Pharmacotherapy, 2007
- Pharmacokinetics of Intravenous Linezolid in Cerebrospinal Fluid and Plasma in Neurointensive Care Patients with Staphylococcal Ventriculitis Associated with External Ventricular DrainsAntimicrobial Agents and Chemotherapy, 2007
- Serum and Cerebrospinal Fluid Concentrations of Linezolid in Neurosurgical PatientsAntimicrobial Agents and Chemotherapy, 2006
- Linezolid pharmacokinetics in pediatric patients: an overviewThe Pediatric Infectious Disease Journal, 2003
- Linezolid for the treatment of complicated skin and skin structure infections in childrenThe Pediatric Infectious Disease Journal, 2003
- Linezolid versus vancomycin for treatment of resistant Gram-positive infections in childrenThe Pediatric Infectious Disease Journal, 2003
- Cerebrospinal Fluid Linezolid Concentrations in Postneurosurgical Central Nervous System InfectionsAntimicrobial Agents and Chemotherapy, 2002
- Single dose pharmacokinetics of linezolid in infants and childrenThe Pediatric Infectious Disease Journal, 2000